CD8A and Kaposi's sarcoma: In PLHIV, administration of pomalidomide at 5 mg for 21 days for the treatment of Kaposi Sarcoma activated CD4+ and CD8+ T-cells, reduced T-cell senescence and expanded central memory CD4+ and CD8+ T-cells.19